Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b

Area of Science:

• Molecular biology
• Cancer research
• Cell signaling

Background:

• Rac1, a small GTPase, regulates cell growth and cytoskeletal dynamics.
• Constitutively activating Rac1 mutations transform cell lines but their in vivo relevance is unknown.
• Investigating Rac1 mutations in breast cancer is crucial for understanding tumorigenesis.

Purpose of the Study:

• To investigate in vivo mutations of Rac1 in breast cancer tissues.
• To identify novel Rac1 isoforms or alterations in breast cancer.
• To correlate Rac1 expression and localization with breast cancer progression and recurrence.

Main Methods:

• Reverse transcription-polymerase chain reaction (RT-PCR) and sequencing of Rac1 in breast cancer tissues and cell lines.
• Identification and characterization of Rac1 isoforms using molecular assays.
• Northern and Western blot analyses for Rac1 RNA and protein expression.
• Immunohistochemical staining to assess Rac1 localization and expression in tissue samples.

Main Results:

• No constitutively activating Rac1 point mutations were detected in vivo; only single-nucleotide polymorphisms were found.
• A novel Rac1 isoform, Rac1b, with a 19-codon insertion near switch region II, was identified.
• Rac1 RNA and protein expression were significantly elevated in breast cancer tissues compared to normal tissues.
• High Rac1 expression was observed in ductal carcinoma-in-situ, primary tumors, and metastases.
• Rac1 plasma membrane localization in recurrent breast cancer suggests activation in aggressive disease.

Conclusions:

• Rac1 activation, rather than specific activating mutations, may drive breast cancer progression.
• The novel Rac1b isoform warrants further investigation for its role in cancer.
• Elevated Rac1 expression and specific localization are potential biomarkers for aggressive breast cancer.